Xuebijing injection for improving sepsis outcomes
Part of Infections clinical trials.
This trial tests whether a herbal injection called Xuebijing, plus standard care, can improve recovery from sepsis. It aims to find new markers in the blood that may help predict how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sepsis, according to current medical criteria.
- You are between 18 and 75 years old.
- You are not pregnant or breastfeeding.
- You do not have other severe conditions like cancer, serious blood disorders, or HIV.
- You have not used immunosuppressant drugs or had an organ transplant in the last 6 months.
- You do not have a recent heart attack or other conditions affecting blood vessel health.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a Chinese herbal medicine called Xuebijing, given as an injection, to see if it helps people with sepsis recover better. It is being studied in real-world hospital settings to understand how well it works outside of strict research conditions.
This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This study tests whether a traditional Chinese medicine called Shenfu injection can improve the flexibility of the carotid artery in people with sepsis or septic shock. It may help doctors understand if this treatment can reduce complications from severe infections.
This trial studies how well a simple check (the 'modified shock index') can predict the outlook for patients with sepsis in the emergency department. The goal is to help doctors identify who might be at higher risk so they can provide faster, more targeted care.
This trial tests a treatment made from human umbilical cord cells to help the body fight severe infections (sepsis). It might reduce inflammation and improve recovery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.